Form 8-K - Current report:
SEC Accession No. 0001493152-24-050830
Filing Date
2024-12-19
Accepted
2024-12-19 17:30:45
Documents
27
Period of Report
2024-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 78385
2 ex3-1.htm EX-3.1 65423
3 ex3-2.htm EX-3.2 254484
4 ex10-1.htm EX-10.1 181095
5 ex10-2.htm EX-10.2 40386
6 ex10-3.htm EX-10.3 305757
7 ex10-4.htm EX-10.4 41472
8 ex99-1.htm EX-99.1 18894
9 ex3-1_001.jpg GRAPHIC 11252
10 ex3-1_002.jpg GRAPHIC 402221
11 ex3-1_003.jpg GRAPHIC 390405
12 ex3-1_004.jpg GRAPHIC 411826
13 ex3-1_005.jpg GRAPHIC 446739
14 ex3-1_006.jpg GRAPHIC 189346
15 ex10-1_001.jpg GRAPHIC 172219
  Complete submission text file 0001493152-24-050830.txt   4116576

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE mgrx-20241213.xsd EX-101.SCH 3033
17 XBRL LABEL FILE mgrx-20241213_lab.xml EX-101.LAB 34240
18 XBRL PRESENTATION FILE mgrx-20241213_pre.xml EX-101.PRE 24177
29 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3848
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 241564321
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)